Basic Information


GTO ID GTC3719
Trial ID NCT06208878
Disease Hematological Malignancy
TherapyCAR-T cell
Treatment CRISPR CAR T cells
Recruitment statusEnrolling By Invitation
TitleA Long-term Follow-up Study of Subjects With Malignancies Treated With CRISPR CAR T Cellular Therapies
Year2023
CountryUnited States
Company sponsorCRISPR Therapeutics AG
Other ID(s)CRSP-ONC-LTF

Clinical Result

Cohort 1
Administration route None
Pts 70
Age Adult, Older_Adult

Relationship Graph

Overview of Knowledge Graph